Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
63%
Symptomatic Treatment
37%
General Practitioner
23%
Cancer Therapy
21%
Advance Care Planning
19%
Cohort Analysis
19%
Symptom
16%
Disease
15%
Bone Metastasis
15%
End of Life Care
13%
Adjuvant Chemotherapy
13%
Oxaliplatin
12%
Randomized Controlled Trial
12%
Primary Health Care
12%
Late Effect
11%
Terminal Illness
11%
Cross Sectional Study
10%
Recurrent Disease
9%
Persistent Pain
9%
Radiation Therapy
9%
Catastrophic Illness
9%
Side Effect
8%
Cancer Diagnosis
8%
Axillary Lymph Node
8%
Prospective Study
8%
Quality of Life
8%
Mindfulness-Based Cognitive Therapy
7%
Computer Assisted Tomography
7%
Intervention Study
7%
Grief
7%
Cold Allodynia
7%
Prevalence
7%
Occupational Rehabilitation
6%
Distress Syndrome
6%
Neuropathy
6%
Magnetic Resonance Imaging
6%
Diffusion MRI
6%
Rehabilitation Engineering
5%
Adjuvant Endocrine Therapy
5%
Survival Time
5%
Capecitabine
5%
Nurse
5%
Head and Neck Cancer
5%
Odds Ratio
5%
Nursing and Health Professions
Malignant Neoplasm
81%
Palliative Therapy
47%
Breast Cancer
42%
General Practitioner
26%
Advance Care Planning
23%
Prevalence
18%
End of Life Care
16%
Cohort Analysis
16%
Bereavement
14%
Symptom
13%
Home Care
12%
Patient Preference
11%
Disease
11%
Cognitive Therapy
11%
Mindfulness
11%
Primary Medical Care
9%
Cross-Sectional Study
9%
Depression
8%
Bereavement Support
8%
Primary Health Care
7%
Confidence Interval
7%
Health Care Personnel
7%
House Call
6%
Health Practitioner
6%
General Practice
6%
Shared Care
6%
Distress Syndrome
6%
Odds Ratio
5%
Cancer Recurrence
5%
Cancer Diagnosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
47%
Chemotherapy
24%
Oxaliplatin
20%
Docetaxel
15%
Symptom
14%
Cross-Sectional Study
12%
Neuropathy
11%
Chemotherapy-Induced Peripheral Neuropathy
10%
Malignant Neoplasm
8%
Polyneuropathy
8%
Endocrine Therapy
8%
Cold Allodynia
7%
Ribociclib
7%
Head and Neck Cancer
6%
Capecitabine
5%
Clinical Trial
5%
